NEWS AND VIEWS FROM THE PHARMACEUTICAL FINE CHEMICAL AND CUSTOM MANUFACTURING SECTOR

Wednesday 3 February 2010

Dishman restructures Carbogen Amcis

Dishman is restructuring its Carbogen Amcis subsidiary. Staff levels have been cut by 20% and a new CEO - currently working at another company in the sector - will join in March. Q3 sales at Carbogen Amcis fell 27% this year and the company expects to save CHF8m through the restructuring.
Business Standard

No comments: